Stem cells

Biologics for regeneration

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Degenerative diseases are a growing epidemic. Pharmacotherapy aimed at treating the root cause of these diseases, namely, progressive cell destruction and irreversible loss of tissue function, is largely lacking. The disease burden creates an evergrowing need for the development of effective therapies that can repair underlying pathobiology and restore native cellular architecture and organ function. Regenerative pharmacology offers a new frontier for medical therapy. Research and development of stem cell-based biologics aims to establish progenitor cells as effective and safe drugs for achieving structural and functional therapeutic repair in practice.

Original languageEnglish (US)
Pages (from-to)620-623
Number of pages4
JournalClinical Pharmacology and Therapeutics
Volume84
Issue number5
DOIs
StatePublished - Nov 2008

Fingerprint

Biological Products
Regeneration
Stem Cells
Therapeutics
Pharmacology
Drug Therapy
Research
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Stem cells : Biologics for regeneration. / Nelson, Timothy J; Behfar, Atta; Terzic, Andre.

In: Clinical Pharmacology and Therapeutics, Vol. 84, No. 5, 11.2008, p. 620-623.

Research output: Contribution to journalArticle

@article{24d0168563be40d5ac4cd3cab1dc496e,
title = "Stem cells: Biologics for regeneration",
abstract = "Degenerative diseases are a growing epidemic. Pharmacotherapy aimed at treating the root cause of these diseases, namely, progressive cell destruction and irreversible loss of tissue function, is largely lacking. The disease burden creates an evergrowing need for the development of effective therapies that can repair underlying pathobiology and restore native cellular architecture and organ function. Regenerative pharmacology offers a new frontier for medical therapy. Research and development of stem cell-based biologics aims to establish progenitor cells as effective and safe drugs for achieving structural and functional therapeutic repair in practice.",
author = "Nelson, {Timothy J} and Atta Behfar and Andre Terzic",
year = "2008",
month = "11",
doi = "10.1038/clpt.2008.146",
language = "English (US)",
volume = "84",
pages = "620--623",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Stem cells

T2 - Biologics for regeneration

AU - Nelson, Timothy J

AU - Behfar, Atta

AU - Terzic, Andre

PY - 2008/11

Y1 - 2008/11

N2 - Degenerative diseases are a growing epidemic. Pharmacotherapy aimed at treating the root cause of these diseases, namely, progressive cell destruction and irreversible loss of tissue function, is largely lacking. The disease burden creates an evergrowing need for the development of effective therapies that can repair underlying pathobiology and restore native cellular architecture and organ function. Regenerative pharmacology offers a new frontier for medical therapy. Research and development of stem cell-based biologics aims to establish progenitor cells as effective and safe drugs for achieving structural and functional therapeutic repair in practice.

AB - Degenerative diseases are a growing epidemic. Pharmacotherapy aimed at treating the root cause of these diseases, namely, progressive cell destruction and irreversible loss of tissue function, is largely lacking. The disease burden creates an evergrowing need for the development of effective therapies that can repair underlying pathobiology and restore native cellular architecture and organ function. Regenerative pharmacology offers a new frontier for medical therapy. Research and development of stem cell-based biologics aims to establish progenitor cells as effective and safe drugs for achieving structural and functional therapeutic repair in practice.

UR - http://www.scopus.com/inward/record.url?scp=54249108861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54249108861&partnerID=8YFLogxK

U2 - 10.1038/clpt.2008.146

DO - 10.1038/clpt.2008.146

M3 - Article

VL - 84

SP - 620

EP - 623

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 5

ER -